Filing Flows › CVS Health (CVS) › Q3 2026 › vs Q3 2025
CVS Health (CVS) Q3 2026 vs Q3 2025 (year over year)
CVS Health's revenue rose $5.5B (+5%) from $102.9B in Q3 2025 to $108.4B in Q3 2026. Operating margin 3.3% against -3.1% (+6.4 pts).
CVS Health, Q3 2026: revenue $108.4B (+5% year over year), operating margin 3.3%, net earnings $2.2B, operating cash flow $4.7B. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 3.3% | -3.1% | +6.4 pts |
| Net margin | 2.0% | -3.9% | +5.9 pts |
| Free cash flow margin | 3.6% | 0.1% | +3.5 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $108.4B | $102.9B | $5.5B | +5% |
| Operating profit | $3.6B | −$3.2B | $6.8B | — |
| Costs & expenses | $104.8B | $106.1B | −$1.2B | -1% |
| Pre-tax earnings | $2.8B | −$3.5B | $6.3B | — |
| Other expense, net | $717M | $275M | $442M | +161% |
| Cost of revenue | $61.2B | $57.0B | $4.1B | +7% |
| Other operating costs | $43.6B | $49.0B | −$5.4B | -11% |
| Net earnings | $2.2B | −$4.0B | $6.2B | — |
| Income tax | $678M | $508M | $170M | +33% |
| Depreciation & amortization | $1.1B | $1.1B | −$2.0M | -0.2% |
| Share-based compensation | $168M | $138M | $30.0M | +22% |
| Working capital & other | $1.3B | $3.5B | −$2.3B | -64% |
| Operating cash flow | $4.7B | $796M | $3.9B | +493% |
| Free cash flow (OCF − capex) | $3.9B | $98.0M | $3.8B | 40× |
| Capital expenditures | $817M | $698M | $119M | +17% |
Questions
How much did CVS Health's revenue grow year over year in Q3 2026?
CVS Health's revenue rose $5.5B (+5%) from $102.9B in Q3 2025 to $108.4B in Q3 2026. Operating margin 3.3% against -3.1% (+6.4 pts).